GGrantIndex
← Leaderboards

Scott James Weir

University Of Kansas Medical Center

$2,961,565
Attributed
$5,420,153
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $976.4K · FY201125
$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,420,153 · 6

By mechanism

R01$2,558,460 · 1
R44$1,912,633 · 1
P30$545,999 · 2
UL1$334,563 · 1
U13$68,498 · 1

Top collaborators

Most similar at University Of Kansas Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “In Vitro

Research focus

In VitroIn VivoClinical TrialsPharmaceutical PreparationsPre-ClinicalLeadKansasNotch ProteinUniversitiesBiological MarkersMalignant NeoplasmsDrug TargetingDrug DiscoveryCancer CenterDesignAreaProgramsPreclinical StudyProteinsDrug DevelopmentNovel Therapeutic InterventionCancer TherapyClinical ResearchDrug Kinetics

Grant awards (16)

Lead Development & Optimization Shared Resource$123,337
P30 · FY2025 · CA · contact PI
Lead Development & Optimization Shared Resource$121,746
P30 · FY2024 · CA · contact PI
Lead Development & Optimization Shared Resource$120,192
P30 · FY2023 · CA · contact PI
Development of Ciclopirox Prodrug as a Novel Systemic Treatment for High-Risk Non-Muscle Invasive Bladder Cancer$976,393
R44 · FY2021 · CA
Development of Ciclopirox Prodrug as a Novel Systemic Treatment for High-Risk Non-Muscle Invasive Bladder Cancer$936,240
R44 · FY2020 · CA
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy$661,842
R01 · FY2018 · CA
Drug Discovery, Delivery, & Experimental Therapeutics Research Program$73,510
P30 · FY2018 · CA · contact PI
Drug Discovery, Delivery, & Experimental Therapeutics Research Program$16,666
P30 · FY2018 · CA · contact PI
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy$688,666
R01 · FY2017 · CA
Drug Discovery, Delivery, & Experimental Therapeutics Research Program$83,018
P30 · FY2017 · CA · contact PI
Drug Discovery, Delivery, & Experimental Therapeutics Research Program$7,530
P30 · FY2017 · CA · contact PI
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy$628,483
R01 · FY2016 · CA
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy$67,777
R01 · FY2015 · CA
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy$511,692
R01 · FY2014 · CA
Drug Repurposing and Rediscovery for Gastrointestinal Stromal Tumors$334,563
UL1 · FY2012 · TR
Annual Conference on Development of Robust Experimental Assay Methods (DREAM)$68,498
U13 · FY2011 · MH · contact PI